PTEN is a protein tyrosine phosphatase for IRS1

Nature Structural and Molecular Biology

Volumn 21, Issue 6, 2014, Pages 522-527

  Shi, Yuji ^a   Wang, Junru ^a   Chandarlapaty, Sarat ^a   Cross, Justin ^a   Thompson, Craig ^a   Rosen, Neal ^a   Jiang, Xuejun ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LIPID; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN TYROSINE PHOSPHATASE; RECOMBINANT PROTEIN; SHORT HAIRPIN RNA; SOMATOMEDIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE NEDD4;

ARTICLE; CELL GROWTH ASSAY; DEPHOSPHORYLATION; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GLUCOSE METABOLISM; HEK293 CELL LINE; HUMAN; HUMAN CELL; OBESITY; PATHOPHYSIOLOGY; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

MAMMALIA;

ANIMALS; CELLS, CULTURED; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE DELETION; GENE KNOCKDOWN TECHNIQUES; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MICE; PHOSPHORYLATION; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SOMATOMEDINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84901997517     PISSN: 15459993     EISSN: 15459985     Source Type: Journal    
DOI: 10.1038/nsmb.2828     Document Type: Article

References (44)

1. Steck, P.A. et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15, 356-362 (1997). (Pubitemid 27147102)
2. Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947 (1997). (Pubitemid 27148818)
3. Song, M.S., Salmena, L. & Pandolfi, P.P. The functions and regulation of the PTEN tumour suppressor. Nat. Rev. Mol. Cell Biol. 13, 283-296 (2012).
4. Parsons, R. & Simpson, L. PTEN and cancer. Methods Mol. Biol. 222, 147-166 (2003).
5. Engelman, J.A., Luo, J. & Cantley, L.C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606-619 (2006). (Pubitemid 44100518)
6. Stambolic, V. et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95, 29-39 (1998). (Pubitemid 28458022)
7. Suzuki, A. et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr. Biol. 8, 1169-1178 (1998). (Pubitemid 28494715)
8. Lu, Y. et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene 18, 7034-7045 (1999). (Pubitemid 30028874)
9. Maehama, T. & Dixon, J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378 (1998). (Pubitemid 28268370)
10. Li, D.M. & Sun, H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β. Cancer Res. 57, 2124-2129 (1997). (Pubitemid 27247025)
11. Lee, J.O. et al. Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-334 (1999).
12. Myers, M.P. et al. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc. Natl. Acad. Sci. USA 94, 9052-9057 (1997).
13. Maier, D. et al. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res. 59, 5479-5482 (1999). (Pubitemid 29526461)
14. Tamura, M., Gu, J., Takino, T. & Yamada, K.M. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59, 442-449 (1999). (Pubitemid 29048881)
15. Tibarewal, P. et al. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity. Sci. Signal. 5, ra18 (2012).
16. Zhang, X.C., Piccini, A., Myers, M.P., Van Aelst, L. & Tonks, N.K. Functional analysis of the protein phosphatase activity of PTEN. Biochem. J. 444, 457-464 (2012).
17. Wang, X. & Jiang, X. Post-translational regulation of PTEN. Oncogene 27, 5454-5463 (2008).
18. Keniry, M. & Parsons, R. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27, 5477-5485 (2008).
19. Wang, X. et al. NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128, 129-139 (2007). (Pubitemid 46048884)
20. Trotman, L.C. et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141-156 (2007). (Pubitemid 46048885)
21. Fouladkou, F. et al. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc. Natl. Acad. Sci. USA 105, 8585-8590 (2008). (Pubitemid 351987724)
22. Drinjakovic, J. et al. E3 ligase Nedd4 promotes axon branching by downregulating PTEN. Neuron 65, 341-357 (2010).
23. Christie, K.J., Martinez, J.A. & Zochodne, D.W. Disruption of E3 ligase NEDD4 in peripheral neurons interrupts axon outgrowth: linkage to PTEN. Mol. Cell. Neurosci. 50, 179-192 (2012).
24. Howitt, J. et al. Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia. J. Cell Biol. 196, 29-36 (2012).
25. Guo, H. et al. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Cell Reports 1, 472-482 (2012).
26. Yim, E.K. et al. Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell 15, 304-314 (2009).
27. Mund, T. & Pelham, H.R. Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2. Proc. Natl. Acad. Sci. USA 107, 11429-11434 (2010).
28. Cao, X.R. et al. Nedd4 controls animal growth by regulating IGF-1 signaling. Sci. Signal. 1, ra5 (2008).
29. Chen, W.S. et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev. 15, 2203-2208 (2001). (Pubitemid 32843832)
30. Cho, H., Thorvaldsen, J.L., Chu, Q., Feng, F. & Birnbaum, M.J. Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem. 276, 38349-38352 (2001).
31. Liu, J.P., Baker, J., Perkins, A.S., Robertson, E.J. & Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75, 59-72 (1993). (Pubitemid 23306021)
32. Taniguchi, C.M., Emanuelli, B. & Kahn, C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96 (2006). (Pubitemid 43278292)
33. Maccario, H., Perera, N.M., Gray, A., Downes, C.P. & Leslie, N.R. Ubiquitination of PTEN (phosphatase and tensin homolog) inhibits phosphatase activity and is enhanced by membrane targeting and hyperosmotic stress. J. Biol. Chem. 285, 12620-12628 (2010).
34. Davidson, L. et al. Suppression of cellular proliferation and invasion by the concerted lipid and protein phosphatase activities of PTEN. Oncogene 29, 687-697 (2010).
35. Lackey, J. et al. Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling. Oncogene 26, 7132-7142 (2007). (Pubitemid 350059678)
36. Chandarlapaty, S. et al. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity. Cancer Cell 19, 58-71 (2011).
37. Goldstein, B.J., Bittner-Kowalczyk, A., White, M.F. & Harbeck, M. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B: possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J. Biol. Chem. 275, 4283-4289 (2000). (Pubitemid 30094668)
38. Galic, S. et al. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol. Cell. Biol. 25, 819-829 (2005). (Pubitemid 40096601)
39. Tiganis, T. PTP1B and TCPTP: nonredundant phosphatases in insulin signaling and glucose homeostasis. FEBS J. 280, 445-458 (2013).
40. Casaletto, J.B. & McClatchey, A.I. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat. Rev. Cancer 12, 387-400 (2012).
41. Anindya, R., Aygün, O. & Svejstrup, J.Q. Damage-induced ubiquitylation of human RNA polymerase II by the ubiquitin ligase Nedd4, but not Cockayne syndrome proteins or BRCA1. Mol. Cell 28, 386-397 (2007). (Pubitemid 350047546)
42. Yang, B. et al. Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nat. Immunol. 9, 1356-1363 (2008).
43. Lin, Q. et al. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK. Mol. Cell. Biol. 30, 1541-1554 (2010).
44. Persaud, A. et al. Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays. Mol. Syst. Biol. 5, 333 (2009).